Mechanism of Progestin Resistance in Endometrial Precancer/Cancer Through Nrf2-Akr1c1 Pathway

Oncotarget - United States
doi 10.18632/oncotarget.7004
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Progestin Therapy for Endometrial Cancer: The Potential of Fourth-Generation Progestin (Review)

International Journal of Oncology
Cancer ResearchOncology
2012English

Biomarkers Needed to Predict Progestin Response in Endometrial Cancer

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2017English

Study of the Characterization of Side Population Cells in Endometrial Cancer Cell Lines: Chemoresistance, Progestin Resistance, and Radioresistance

Frontiers in Medicine
Medicine
2020English

P62 Suppressed VK3-induced Oxidative Damage Through Keap1/Nrf2 Pathway in Human Ovarian Cancer Cells

Journal of Cancer
Oncology
2020English

Hsa_circ_0079662 Induces the Resistance Mechanism of the Chemotherapy Drug Oxaliplatin Through the TNF-α Pathway in Human Colon Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A Review of the Literature

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer

Annual Review of Cancer Biology
2020English

IDH1 R132H Mutation Regulates Glioma Chemosensitivity Through Nrf2 Pathway

Oncotarget
Oncology
2017English

Treatment Efficiency of Comprehensive Hysteroscopic Evaluation and Lesion Resection Combined With Progestin Therapy in Young Women With Endometrial Atypical Hyperplasia and Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy